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ABSTRACT Gingivitis and periodontitis are chronic inflammatory diseases of the periodontal tissue in humans 
caused by both environmental and genetic factors. The human cytokine genes that regulate the immune re-
sponse may play an important role in the development of these chronic inflammatory diseases. The aim of this 
study is to analyze the allele status of eight human cytokine genes and to associate it with the inflammation of 
periodontal tissue in humans.  A total of 296 unrelated males of Russian origin were studied. A significant asso-
ciation of the IL1B and IL6 minor alleles and gingivitis was found.  In addition, we found a significant association 
of the OHI-S index with the IL18 gene alleles. The influence of genetic factors on gingivitis may contribute to 
the understanding of the mechanisms of interaction between genetic and environmental factors in periodontal 
conditions, and to the identification of risk groups for effective prevention and treatment.
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INTRODUCTION
Gingivitis (inflammation of the gum tissue) and peri-
odontitis (inflammation of tissues surrounding and sup-
porting the teeth) are widespread oral diseases. Gingi-
vitis can appear both in tandem with periodontitis and 
independently. Signs of periodontal tissue involvement 
might appear even in children 6—7 years old [1]; these   
indicators are found in more than 50% of 15-year-old 
adolescents, and the prevalence of periodontal diseases 
among adults in Moscow and other large cities reaches 
98%. Moreover, symptoms of gingivitis are found in 
more than 80% of people [2].
The inflammation and the destruction of tissues in 
periodontal diseases occur due to a disequilibrium in 
the interaction between periodontal cells and bacteria 
found in the mouth, in particular in dental deposit. The 
pathogenic processes typical of gingivitis and periodon-
titis are caused by the immunopathological reaction, 
which, in turn, is initiated by bacteria present in dental 
deposit. This reaction leads to a progressing wavelike 
chronic inflammation, which is accompanied by the de-
velopment of destructive processes.
The regulation of the inflammatory response is 
known to play an important role in the pathogenesis of 
gingivitis and perodontitis [3]. A study of transcriptome 
changes in the gingival biopsies during the develop-
ment and treatment of experimental gingivitis showed 
that, during the development of the disease, there are 
changes in the expression level of tens of immune re-
sponse genes, including interleukins IL1A, IL1B, IL8 
and a number of other genes[4]. In this instance, the 
transcription level of one gene increases, whilst the 
level of other genes decreases.
The role of an individual’s genetic constitution in 
their predisposition to inflammatory diseases of the 
periodontal tissue and to the intensity of their pro -
gression has been inadequately studied thus far. As-
sociation studies reveal that carriers of certain cytokine 
gene alleles are more prone to develop gingivitis and/
or periodontitis [5—9]. However, these data are rather 
contradictory [6, 10, 11].
The purpose of the present work is to study the asso-
ciation between the severity of the periodontal disease 
and the alleles affecting the transcription level of eight 
human cytokine genes, the level of which determines 
the severity of the inflammation and destructive proc-
esses in periodontal tissues. The results could allow to 
identify potential risk groups of inflammatory peri-
odontal diseases and can later be used in preventive, 
personalized medicine.
EXPERIMENTAL
A group of 296 male soldiers from 20 to 52 years of age 
(the average age is 27.0 ± 6.3 years) was examined. The 
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examination was performed during a routine medical 
examination; the procedure of informed consent was 
followed; the data were collected on the nationality and 
place of birth of the volunteers and two generations of 
their ancestors. The examined group included mainly 
Russian males (proportion of children from mixed mar-
riages (the percentage of descendants from mixed mar-
riages between Russians, Ukrainians, and Belarusians 
was 6.5%)). All patients underwent a standard external 
dental checkup and instrumental examination of the 
oral cavity. The description of the dental status con-
tained the assessment of the intensity of inflammation 
and destructive processes and the index of oral hy-
giene.
For the assessment of the severity of gingivitis, the 
PMA (papillary-marginal-alveolar) index was used [12]. 
In order to determine this index, the condition of gum 
tissue for each tooth was assessed in points after it was 
stained with the purpose of revealing the inflamed ar-
eas; the value averaged over all teeth was calculated. 
PMA = 0 corresponds to the absence of gingivitis, PMA 
values of up to 30% inclusive correspond to mild gingi-
vitis, the range from 31% to 60% corresponds to gingivi-
tis of moderate severity, whereas PMA values of more 
than 60% correspond to severe gingivitis.
The examination of the probing pocket depth (PPD) 
was performed using a special periodontal probe. The 
highest value of the PPD (mm) was registered, and all 
values were then summarized and categorized by the 
number of teeth examined.
The hygiene condition of the oral cavity (the amount 
of dental calculus and dental deposit) was assessed in 
accordance with the OHI-S (oral hygiene indices – sim-
plified) index [13].
Samples of venous blood were collected into evacu-
ated tubes containing EDTA. DNA was extracted 
from the blood samples using the standard phenol-
chloroform method. The alleles of the genes analyzed 
were genotyped twice using an “Immunogenetics” kit 
(DNA-technology, Moscow). PCR amplification and 
genotyping were carried out in 384 well plates us -
ing a DT-384 amplifier (DNA-technology, Moscow). 
Eight cytokine genes were investigated: γ-interferon 
(IFN-γ); α- and β-subunits of interleukin 1 (IL-1α and 
IL-1β); IL-4, IL-6, IL-10, IL-18 interleukins; and tu-
mor necrosis factor α (TNFα) (Table 1). Polymorphic 
Table 1. SNPs of cytokine genes checked in this work
Gene Chromosome SNP dbSNP ID Function Ref.
IFNG 12q14 +874 Т>A rs2430561
Increasing the expression of HLA II by antigen-repre-
senting cells, increasing the level of intercellular adhesion 
molecules, increasing the level of proliferation of T-cells 
and production of Th1-cytokines 
[14]
IL1A 2q14 -889 C>T rs1800587 Anti-inflammation cytokine. 
Activation of osteoclasts, T-cells, and matrix metal 
proteases 
[15, 16]
IL1B 2q14 -511 G>A rs16944
IL4 5q31.1 -590 C>T rs2243250
Decreasing the level of anti-inflammation cytokine.  
Involvement in differentiation of B-cells and production 
of antibodies 
[17]
IL6 7p21 -174 G>C rs1800795 Activation of osteoclasts. Involvement in differentiation of 
B-cells and production of antibodies [18]
IL10 1q31-q32 -592 C>A rs1800872
Inhibiting replication of T-cells and inhibiting synthesis of 
anti-inflammation cytokine. Involvement in differentia-
tion of B-cells and production of antibodies 
[18]
IL18 11q22.2-q22.3 -607 G/T rs1946518 Anti-inflammation cytokine. 
Increasing the level of producing IFN-γ by Т-cells. [19-21]
TNF  6p21.3 -308 G>A rs1800629
Activation of osteoclasts and matrix metal proteases. 
Increasing the expression of HLA II by antigen-repre-
senting cells. Increasing the level of intercellular adhesion 
molecules
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SNPs predominantly from the promoter regions, af-
fecting the expression of the indicated genes, were 
selected for analysis. The polymorphic SNPs are listed 
in Table 2.
A statistical analysis was carried out by the stand-
ard methods using the WinSTAT 2003.1 software in-
tegrated into the Excel software. For the intergroup 
comparison of the dental indices, the nonparametric 
Mann-Whitney criterion was used. We used WinPepi 
freeware, http://www.brixtonhealth.com/pepi4win-
dows.html [22], to estimate the odds ratio (OR) and the 
significance of the differences between the frequencies 
in accordance with the Fisher’s exact test. Corrections 
for multiple comparisons were introduced by the per-
mutation test (100,000 stimulations) performed using 
the Mathematica 5.1 software.
RESULTS AND DISCUSSION
In only 1% (three patients) of the group examined 
(296 males), no sign of inflammation of gum tissue 
Table 2. Mean values of the dental indices in carriers of some genotypes over eight cytokine genes
Genotype N
Dental indices (±SE)*
Minor allele effect**
PMA PPD OHI-S
IFNG (+874)
A/A 67 0.25±0.02 1.61±0.10 1.85±0.09
p > 0.2 for all indices T/A 127 0.22±0.01 1.42±0.06 1.74±0.07
T/T 87 0.24±0.04 1.48±0.07 1.78±0.07
IL1A (-889)
C/C 140 0.22±0.01 1.40±0.06 1.72±0.06
PMA↓  
Recessive р = 0.026 C/T 118 0.26±0.02 1.59±0.07 1.84±0.07
T/T 27 0.20±0.02 1.45±0.11 1.79±0.12
IL1B (-511)
A/A 29 0.26±0.03 1.41±0.11 1.77±0.12
PMA↑
Recessive р = 0.157 G/A 122 0.23±0.02 1.44±0.07 1.80±0.07
G/G 133 0.22±0.01 1.49±0.06 1.76±0.06
IL4 (-590)
C/C 171 0.24±0.01 1.49±0.06 1.79±0.05
р > 0.5
for all indexes C/T 98 0.23±0.02 1.45±0.07 1.78±0.07
T/T 14 0.19±0.04 1.51±0.22 1.57±0.20
IL6 (-174)
C/C 61 0.25±0.02 1.53±0.10 1.70±0.07
PMA↑
Dominant p = 0.003 G/C 139 0.24±0.01 1.48±0.06 1.83±0.07
G/G 85 0.21±0.02 1.46±0.08 1.74±0.08
IL10 (-592)
A/A 23 0.24±0.03 1.57±0.15 1.66±0.16
OHI-S↓
Dominant р = 0.043 C/A 110 0.22±0.01 1.46±0.07 1.72±0.06
C/C 152 0.24±0.01 1.49±0.06 1.84±0.06
IL18 (-607)
C/C 85 0.25±0.02 1.50±0.08 1.69±0.07 OHI-S↑
Recessive р = 0.022;
PMA↑
recessive р = 0.188
A/C 140 0.21±0.01 1.44±0.06 1.75±0.06
A/A 57 0.27±0.02 1.57±0.09 1.96±0.09
TNF (-308)
A/A 4 0.17±0.04 1.45±0.22 1.83±0.25
р > 0.2
for all indexes G/A 68 0.25±0.02 1.50±0.08 1.84±0.09
G/G 212 0.23±0.03 1.48±0.05 1.76±0.05
*The association level is significant.
**The arrow indicates an increased or decreased value of the character for the minor allele carriers (dominant effect) and 
for homozygous minor allele carriers (recessive effect). The minimum levels of significance are calculated in accordance 
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(PMA = 0) was observed Mild gingivitis was found in 
67.6% of males (205 patients), and 31.4% of males were 
suffering from gingivitis of moderate severity (93 pa-
tients) and severe gingivitis (12 patients) (PMA > 30%). 
The probing pocket depth varied from 0.6 to 4.5 mm. 
The mean value across the group examined was 1.50 ± 
0.73 mm (±S.D.). The values of the OHI-S indices was in 
a range from 0 to 3.8 points, the mean value was 1.79 ± 
0.73; it corresponds to an unsatisfactory hygiene level. 
The genotypes of all males examined were determined 
for each from eight loci. Due to technical difficulties, 
the genotypes of some SNPs were not determined for 
each individual; hence, the total number of genotypes 
for each gene is different.
The dental indices can be considered as quantitative 
characters; hence, in order to assess how genes influ-
ence the value of the characters, the mean values of 
the indices for the investigated genes were calculated 
in carriers of each genotype. The significant differences 
between the mean values of the indices for carriers of 
different genotypes indicate the possible influence of a 
gene on a given character. In this case, the differences 
between the carriers of the considered allele and the 
carriers not having this allele (homozygous alternative 
allele carriers) indicate the dominant effect of the con-
sidered allele and the recessive effect of the alterna-
tive allele. An increase in character, depending on the 
number of copies of the allele in the genotype (0, 1 or 
2), corresponds to the additive model (the significance 
of the regression of the character value per number of 
allele copies is determined).
The mean values of dental indices were calculated 
in carriers of different genotypes over eight cytokine 
genes (Table 2). The significance levels of the effects 
of minor alleles calculated by the permutation test 
are contained in the right column of Table 2. The ef-
fects of minor alleles were estimated simultaneously 
in 100,000 permutations in accordance with the domi-
nant, recessive, and additive models. The results of the 
significance were used in order to further verify the 
significance of associations. The additive model gave no 
added significance compared with the analysis results 
on the recessive/dominant effects; thus, the data for 
the additive model are not listed.
A significant increase in the mean PMA index value 
was revealed in carriers of the IL6*(-174)С allele (Table 
2). Since the PMA index value correlates with the age 
of patients (r = 0.16 at p = 0.004), the influence of the 
gene was checked in two age groups: 215 patients were 
up to 30 years old, and 70 patients were 30 years old 
and older).  A significance association of the IL6*(-174)С 
allele with an increased PMA index value according to 
the dominant model is revealed in each age cohort (Fig. 
1). When splitting each age cohort into groups with 
high PMA (>30% corresponds to moderate and severe 
gingivitis) and low (<30% corresponds to normal and 
mild gingivitis), the carriers of the IL6 * (-174) C allele 
showed a greater risk of being in the group of moder-
ate and severe gingivitis. The corresponding odds ratios 
were OR = 2.22 at p = 0.031 in the group of patients 
younger than 30 and OR = 3.78 at p = 0.052 in the group 
of patients 30 years old and older. The uniformity of the 
effects in both age groups (the differences in the OR 
are negligible, p = 0.496 according to the χ
2 criterion) 
allows to estimate the odds ratio in the pooled sample: 
OR = 2.56 at p = 0.002 (95%CI = 1.32—5.21).
Analogous calculations carried out for the IL1A*(-
889) SNP revealed that the carriers of the major C al-
lele are in greater risk of suffering from moderate and 
severe gingivitis (PMA > 30%) in comparison to the 
carriers of the T/T genotype: OR = 3.86 at p = 0.026 
(95%CI = 1.14—13.10).
In addition to the assessment of the individual gene 
effects, their pairwise action was considered.  The pair-
wise action of the minor alleles in the IL6*(-174) SNP of 
the IL6 gene and the IL1B*(-511) SNP of the IL1B gene 
was found, while no significant effects of these genes 
were revealed in the previous stage of analysis. Dur-
ing consideration of the pairwise action of these two 
genes, their influence on the mean PMA value and on 
the association with moderate and severe gingivitis was 
analyzed as in the previous stage.
The lowest mean PMA value was typical of dou -
ble homozygotes for both SNPs.  Upon increase in the 
number of minor alleles in the IL1B*(-511) and IL6*(-
174) SNPs, the mean PMA index value increases (Fig. 
Age
<30
≥30
P
M
A
G/G  G/C  C/C
IL6*(-174)G > C genotypes
0.4
0.3
0.2
0.1
0.0
Fig. 1. Mean values (±SE) of the PMA index in carriers of 
different IL6 (-174) genotypes from two groups: less than 
30 years old, 215 individuals; and more than 30 years old, 
70 individuals.120 | ACTA NATURAE |  VOL. 3  № 1 (8)  2011
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2). The difference in the PMA index values (by a factor 
of 2.3) found for two extreme cases (double homozy-
gotes for the minor alleles and homozygotes for the 
major alleles) are significant according to the Mann-
Whitney test (p = 0.0067).
The distributions of the total number of minor allele 
copies in the IL1B*(-511) and IL6*(-174) SNPs in the 
patients suffering from severe and moderate gingivitis 
(PMA ≥ 30%), from mild gingivitis (PMA < 30%), and 
the healthy patients are shown in Fig. 3.  It can clearly 
be seen that the carriers of at least one minor allele of 
the IL1B*(-511) and IL6*(-174) genes are more likely to 
be found amongst  patients with severe gingivitis. The 
risk of development of moderate and severe gingivitis 
(PMA ≥ 30%) is higher in the homozygous carriers of 
the minor IL1B*(-511)A and IL6*(-174)С alleles than 
in the homozygous carriers of the major IL1B*(-511)G 
and IL6*(-174)G alleles and is characterized by an odds 
ratio OR = 7.63 at p = 0.0009 (95%CI = 1.80—32.45). 
The percentage of homozygous carriers of minor al-
leles (individuals carrying the combination of the A/A 
genotype of the IL1B*(-511) SNP and C/C genotype of 
IL6*(-174) SNP associated with severe gingivitis) was 
1.1%; the percentage of individuals carrying the “pro-
tective” combinations of the G/G and G/G genotypes 
of the same SNPs was 11.3% (32 patients). This effect 
has to be confirmed in larger samples, but an increase 
in the effect occurring upon an increase in the number 
of minor alleles argues for the nonarbitrariness of the 
association revealed (Fig. 2).
The prevention and treatment of periodontal diseas-
es is a very pertinent issue within dentistry. Periodon-
tal diseases are found even in infancy, and apparent 
clinical manifestations of this pathology are observed 
in more than half of people in their 30s. However, the 
problems of prevention and effective treatment of 
periodontal diseases remains unsolved [23]. The man-
ifestations of the clinical signs of this disease depend 
on age, pernicious habits, general health status, and 
overall hygiene. In this context, it is reasonable to con-
sider the phenomenon of the association between the 
OHI-S index and SNPs in the interleukin genes. The 
OHI-S index is increased in homozygous carriers of the 
IL10*(-592)C allele (its value is 1.84 ± 0.06 against 1.71 ± 
0.06 in carriers of the allele A; however the difference 
is insignificant, since p = 0.092 according to the Mann-
Whitney test). Significant differences are observed in 
individuals carrying different genotypes of the IL18*(-
607) SNP, G > A. The value of the OHI-S index in car-
riers of the homozygous A/A genotype is 1.96 ± 0.09, 
while in carriers of the G allele, its value is 1.73 ± 0.05 
(the difference is significant, p = 0.018 according to the 
Mann-Whitney test). It may be assumed that since hy-
giene hardly depends on the genotype, in homozygous 
carriers of the IL18*(-607) А allele, the formation of 
plaques dental deposit is more intensive and pushes up 
the value of the OHI-S index.
No association of the PPD with the alleles of cytokine 
genes was found.
In this work, we established an association between 
the IL1A*(-889)С and IL6*(-174)С alleles and the se- С alleles and the se-  alleles and the se-
verity of gingivitis and the increase in the effect of the 
Number of minor alleles in the  
IL1B(-511) and IL6(-174) SNPs
32  103  113   33   3
0  1  2  3  4
P
M
A
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Fig. 2.  Mean values (±SE) of the PMA index vs. the 
number of minor alleles in the IL1B (-511) and IL6 (-174) 
SNPs. The number of individuals carrying each genotype is 
shown in histogram bars.
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Fig. 3. Distribution of the total number of minor alleles 
copies found in the SNP IL1B (-511) and IL6 (-174) SNPs vs. 
severity of gingivitis. The group of individuals with PMA 
index ≥ 30 (moderate and severe gingivitis) includes 87 
individuals. The group of individuals with PMA index < 30 
(no gingivitis and mild gingivitis) includes 197 individuals.RESEARCH ARTICLES
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IL6*(-174)С allele in the presence of the IL1B*(-511)A 
allele. The 511 A/G polymorphism influences the ex-
pression of the IL1B gene under certain conditions and 
is associated with inflammatory and cancer diseases 
[11, 24]. Interleukin 1 is an anti-inflammatory cytokine 
secreted by monocytes, macrophages, and dendritic 
cells. The IL1gene is one of the first genes for which an 
association of single-nucleotide polymorphisms with in-
flammatory diseases of periodontal tissue was revealed 
in [5]. In the development of a periodontal disease, the 
role of interleukin 1 involves the induction of inflam-
mation mediators.  It has been demonstrated that in 
immortalized human gingival fibroblasts, the tran-
scription level of the inflammatory genes of cytokines, 
chemokines, metalloproteases,  cell adhesion molecules, 
and the  transcription factor NF-kβ, which controls 
the expression of immune and anti-apoptotic response 
genes and cell cycle genes, increase. The activation of 
NF-kβ blocks apoptosis, thereby causing the stabiliza-
tion of gingival fibroblasts in vitro [25]. An association 
of the polymorphic markers in the interleukin 1 gene 
cluster (IL1A, IL1B and IL1RN, IL1 receptor antago-
nist) with periodontitis and gingivitis has been estab-
lished only in a few works [11].
Interleukin 6 is a multifunctional cytokine that plays 
an important role in the inflammatory response on in-
fectious agents (especially gram-negative bacteria) [26]. 
The production of cytokine is decreased in carriers of 
the minor C allele at the -174 position of the regula-
tory site in the IL6 gene; this may cause a destruction 
of the immune protection [27]. While studying the as-
sociations of both genes with the inflammation of peri-
odontal tissue, contradictory data were obtained. An 
analysis of the association between chronic periodonti-
tis and the IL6(-174) SNP performed in six Caucasian 
populations reveal the presence of the association in 
three of them [11]. The interleukin genes may be in-
volved in the regulation of the inflammatory response 
and could be responsible for the differences observed 
in the spectrum of oral pathogens for carriers of dif-
ferent genotypes. The Aggregatibacter actinomycetem-
comitans and Porphyromonas gingivalis pathogenic 
bacteria were revealed to be more frequently found in 
sublingual biofilms for the carriers of a certain geno-
type in the IL6(-174) SNP [8]. The contradictions in the 
results obtained by different authors can be explained 
by changes in the correlation between the factors de-
pending on age, ethnic homogeneity, and other peculi-
arities of the groups examined.
The formation of dental calculus and dental deposit 
is a complex process that depends on the quality of oral 
hygiene, microbiota, and local immunity. Genetically 
determined features of the immune response might 
also influence the formation of dental deposits and, 
consequently, the OHI-S index. Interleukin 18 is an 
anti-inflammatory cytokine, and in all probability it is 
one of the main cytokines involved in the development 
of pathological processes and destruction of periodon-
tal tissues; it is secreted by macrophages/monocytes 
and epithelial cells of the oral cavity, stimulates cellu-
lar immunity and induces the production of IFN-γ. The 
level of interleukin 18 is increased in cases of various 
chronic inflammatory diseases. The content of interleu-
kin 18 in gingival fluid increases proportionally to the 
severity of a periodontal inflammation and decreases 
to its initial level after the disease is cured [28, 29]. The 
-607 C/A SNP in the regulatory site of the IL18 gene is 
localized in the CREB (cAMP response-element bind-
ing protein) site [30]. A significant increase in both the 
spontaneous and lipopolysaccharide-induced produc-
tions of interleukin 18 is observed in the cell culture 
of donors carrying the A allele [31]. The association of 
the OHI-S index with the interleukin gene alleles had 
not been described earlier. The associations revealed 
are significant for the ethnically homogeneous sample 
(Russians) examined. To date, the severity of the in-
flammation and destructive processes in periodontal 
diseases is known to be genetically dependent. These 
diseases should be considered as multifactor diseases 
[11]. However, the contribution of certain genes to the 
predisposition to and tolerance of inflammatory dis-
eases of the periodontal tissue requires a more detailed 
study, especially with different genetic backgrounds, 
which could be ethnically dependent.  Therefore, the 
practical significance of the association revealed here 
makes testing these results in independent samples of 
other ethnic groups especially interesting. 
This work was supported by the Russian Academy of 
Sciences Presidium Program “Fundamental Sciences 
to Medicine.”
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